Diabetic foot ulcer incidence and survival with improved diabetic foot services: an 18-year study
- PMID: 31150130
- PMCID: PMC6852104
- DOI: 10.1111/dme.14045
Diabetic foot ulcer incidence and survival with improved diabetic foot services: an 18-year study
Abstract
Aims: To ascertain the effects of improvements in diabetic foot services over 18 years on incidence of diabetic foot ulceration. We also compared survival time from first ulcer development with presence of neuropathy, peripheral vascular disease, age and healing.
Methods: Persons with new ulceration and those at high risk of ulcer development were referred to community podiatry from 1998. Their details were recorded, with verbal consent, on a central database. The effects of neuropathy, peripheral vascular disease, healing and age on survival were analysed by Cox proportional hazards ratios.
Results: The incidence of first ulcer presentation decreased from 11.1 to 6.1 per 1000 persons between 2003 to 2017 (P <0.0001). Recurrent ulceration incidence remained stable. Prevalence of chronic and new foot ulceration combined increased from 20.7 to 33.1 per 1000 persons (P <0.0001). Ten-year survival was 85% for persons presenting with first ulcer and aged < 65 years, 50% for those aged 65-74 years and 25% for those aged 75-81 years (P < 0.0001). In those with peripheral vascular disease 5-year survival was 35% (P <0.001).
Conclusions: Integrated care for the diabetic foot in one National Health Service (NHS) health service area over 18 years was associated with a reduction in first presentations of diabetic foot ulceration, but failed to reduce recurrent ulceration. Cumulative prevalence of all ulcers continues to increase. Monitoring ulceration incidence can inform audit and planning of diabetic foot care services. Survival is better than reported previously in persons < 65 years and in the absence of peripheral vascular disease.
© 2019 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Figures


Similar articles
-
Ulcer-free survival following management of foot ulcers in diabetes.Diabet Med. 2005 Oct;22(10):1306-9. doi: 10.1111/j.1464-5491.2005.01640.x. Diabet Med. 2005. PMID: 16176187
-
Which diabetic patients should receive podiatry care? An objective analysis.Intern Med J. 2005 Aug;35(8):451-6. doi: 10.1111/j.1445-5994.2005.00880.x. Intern Med J. 2005. PMID: 16176466
-
Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study.Diabetologia. 2009 Mar;52(3):398-407. doi: 10.1007/s00125-008-1226-2. Epub 2008 Nov 27. Diabetologia. 2009. PMID: 19037626
-
[Diabetic, neuropathic, arteriopathic foot and dressing choice].Praxis (Bern 1994). 2012 Nov 14;101(23):1489-95. doi: 10.1024/1661-8157/a001110. Praxis (Bern 1994). 2012. PMID: 23147605 Review. German.
-
The diabetic foot: pathogenesis and clinical evaluation.Semin Vasc Med. 2002 May;2(2):221-8. doi: 10.1055/s-2002-32045. Semin Vasc Med. 2002. PMID: 16222613 Review.
Cited by
-
Insoles to ease plantar pressure in people with diabetes and peripheral neuropathy: a feasibility randomised controlled trial with an embedded qualitative study.Pilot Feasibility Stud. 2023 Feb 3;9(1):20. doi: 10.1186/s40814-023-01252-y. Pilot Feasibility Stud. 2023. PMID: 36737812 Free PMC article.
-
Correction of Foot Deformities from Charcot Arthropathy with the Taylor Spatial Frame: A 7-14-year Follow-up.Strategies Trauma Limb Reconstr. 2021 May-Aug;16(2):96-101. doi: 10.5005/jp-journals-10080-1525. Strategies Trauma Limb Reconstr. 2021. PMID: 34804225 Free PMC article.
-
Amino acid analysis as a method of discovering biomarkers for diagnosis of diabetes and its complications.Amino Acids. 2023 May;55(5):563-578. doi: 10.1007/s00726-023-03255-8. Epub 2023 Apr 17. Amino Acids. 2023. PMID: 37067568 Review.
-
Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers.Diabetes Care. 2023 Jan 1;46(1):209-221. doi: 10.2337/dci22-0043. Diabetes Care. 2023. PMID: 36548709 Free PMC article. Review.
-
Footwear and insole design features for offloading the diabetic at risk foot-A systematic review and meta-analyses.Endocrinol Diabetes Metab. 2020 Apr 11;4(1):e00132. doi: 10.1002/edm2.132. eCollection 2021 Jan. Endocrinol Diabetes Metab. 2020. PMID: 33532602 Free PMC article.
References
-
- Apelqvist J, Larsson J, Agardh CD. Long‐term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485–491. - PubMed
-
- Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE et al Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22: 382–387. - PubMed
-
- Pound N, Chipchase S, Treece K, Game F, Jeffcoate W. Ulcer‐free survival following management of foot ulcers in diabetes. Diabet Med 2005; 22: 1306–1309. - PubMed
-
- Winkley K, Sallis H, Kariyawasam D, Leelarathna LH, Chalder T, Edmonds ME et al Five‐year follow‐up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality. Diabetologia 2012; 55: 303–310. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical